lunes, 5 de enero de 2026

What are the risks and benefits of second-generation anti-VEGF therapy for exudative AMD? (Medscape AI)

https://www.medscape.com/ai-search?query=What%20are%20the%20risks%20and%20benefits%20of%20second-generation%20anti-VEGF%20therapy%20for%20exudative%20AMD%3F&ecd=mkm_ret_251216_mscpmrk_ophth_macular-degeneration_etid7956547&uac=148436CN&impID=7956547

No hay comentarios:

Publicar un comentario